DoMore Diagnostics
Oslo, Norway
DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. To best treat cancer, we must understand how the disease will develop. The Histotype Px® Colorectal marker is able to predict the outcome of a patient’s cancer and can guide a more precise treatment for each patient, and thereby avoid over-and undertreatment. Histotype Px® Colorectal* cancer marker is the most advanced deep convolutional neural network algorithm for determining prognosis in colorectal cancer based on standard histology images.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.domorediagnostics.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of DoMore Diagnostics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now